Bioxcel Therapeutics' IPO

Bioxcel Therapeutics raised a round of funding on March 08, 2018. Investors include Public.

Bioxcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neurosc…

Articles about Bioxcel Therapeutics' IPO: